Evidence map›Paper›PMID 42080601›Full record

ArticleJournal of the American Chemical Society2026

Assessment of Complementary Catalysts in an Uncharted Enantioselective Reaction of Sulfondiimines.

Eden Gaster, Hannah S Slocumb, Zrinko Jurić, Tyler E Myers, Ngiap-Kie Lim, Thomas C Malig, F Dean Toste, Francis Gosselin, Matthew S Sigman, Scott J Miller

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eden GasterDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.
Hannah S SlocumbDepartment of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
Zrinko JurićDepartment of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
Tyler E MyersDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.ORCID 0009-0004-6228-4915
Ngiap-Kie LimDepartment of Synthetic Molecule Process Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.ORCID 0000-0002-3760-4874
Thomas C MaligDepartment of Synthetic Molecule Analytical Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.ORCID 0000-0003-3168-2297
F Dean TosteDepartment of Chemistry, University of California, Berkeley, California 94720, United States.ORCID 0000-0001-8018-2198
Francis GosselinDepartment of Synthetic Molecule Process Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.
Matthew S SigmanDepartment of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.ORCID 0000-0002-5746-8830
Scott J MillerDepartment of Chemistry, Yale University, New Haven, Connecticut 06511, United States.ORCID 0000-0001-7817-1318

Funding

Methods for Selective Organic Synthesis based on Ionic CatalystsR35GM118190 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI F. Dean Toste · 2016 to 2026
$6.7M
Site-Selective Catalysis for Bioactive Scaffold DiversificationR35GM132092 · NIGMS · YALE UNIVERSITY · PI Scott J Miller · 2019 to 2026
$6.3M
Data Science Guided Organic Reaction DevelopmentR35GM136271 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MATTHEW S SIGMAN · 2020 to 2026
$3.5M
NIGMS NIH HHS R35 GM118190NIGMS NIH HHS R35 GM132092NIGMS NIH HHS R35 GM136271
6 · The paper itself

Abstract

Traditionally, many chemists turn to "privileged" catalyst scaffolds, which often demonstrate appreciable performance for a broad range of transformations. However, these structures can be challenging to modify, so complementary catalysts, such as peptides, are of interest. We simultaneously explored both peptidic and privileged cinchona catalysts for the asymmetric trifluoroacetylation of sulfondiimines (SDIs), an unexplored enantioselective reaction. The resultant acylated SDIs can enable access to a broad range of enantioenriched sulfur(VI) products for potential applications as bioisosteres. A significant challenge facing the establishment of an enantioselective variant of this reaction is that the background reaction has a high rate of reactivity, achieving 70% conversion in just 1 h at -78 °C. Nonetheless, we identified both a peptide and a cinchona alkaloid featuring kinetic profiles that outcompete this extremely fast background reactivity by an order of magnitude. Substrate scope was profiled using an algorithmic strategy followed by a comparison of statistical models relating substrate molecular descriptors and ΔΔ

Identifiers

PMID42080601
PMCPMC13185124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.